- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological treatments of COVID-19
Authors
Keywords
-
Journal
Pharmacological Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-20
DOI
10.1007/s43440-020-00152-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Compounds with therapeutic potential against novel respiratory 2019 coronavirus
- (2020) Miguel Angel Martinez ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure analysis of the receptor binding of 2019-nCoV
- (2020) Yun Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
- (2020) Jared S. Morse et al. CHEMBIOCHEM
- Recent discovery and development of inhibitors targeting coronaviruses
- (2020) Thanigaimalai Pillaiyar et al. DRUG DISCOVERY TODAY
- Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020
- (2020) Peng Wu et al. Eurosurveillance
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19
- (2020) Y Song et al. GUT
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
- (2020) Barnaby Edward Young et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Systematic Review of Lopinavir Therapy for SARS Coronavirus and MERS Coronavirus–A Possible Reference for Coronavirus Disease‐19 Treatment Option
- (2020) Tian‐Tian Yao et al. JOURNAL OF MEDICAL VIROLOGY
- Potential interventions for novel coronavirus in China: A systematic review
- (2020) Lei Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019
- (2020) Wenzheng Han et al. JOURNAL OF MEDICAL VIROLOGY
- On the use of corticosteroids for 2019-nCoV pneumonia
- (2020) Lianhan Shang et al. LANCET
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Outbreak of a novel coronavirus
- (2020) Andrea Du Toit NATURE REVIEWS MICROBIOLOGY
- Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
- (2020) Kimiyasu Shiraki et al. PHARMACOLOGY & THERAPEUTICS
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- Remdesivir as a possible therapeutic option for the COVID-19
- (2020) Jaffar A. Al-Tawfiq et al. Travel Medicine and Infectious Disease
- Small RNAs in eucaryotes: new clues for amplifying microRNA benefits
- (2020) Bernardetta Ledda et al. Cell and Bioscience
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Antibodies targeting the interleukin-5 signaling pathway used as add-on therapy for patients with severe eosinophilic asthma: a review of the mechanism of action, efficacy, and safety of the subcutaneously administered agents, mepolizumab and benralizumab
- (2020) Georgios Hillas et al. Expert Review of Respiratory Medicine
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
- (2020) Junxiong Pang et al. Journal of Clinical Medicine
- Rapid and severe Covid‐19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab
- (2020) Gonzalo De Luna et al. AMERICAN JOURNAL OF HEMATOLOGY
- Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
- (2020) J.-M. Michot et al. ANNALS OF ONCOLOGY
- Of chloroquine and COVID-19
- (2020) Franck Touret et al. ANTIVIRAL RESEARCH
- COVID-19 infection and rheumatoid arthritis: Faraway, so close!
- (2020) Ennio Giulio Favalli et al. AUTOIMMUNITY REVIEWS
- Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again
- (2020) Fanqi Wu et al. BRITISH JOURNAL OF HOSPITAL MEDICINE
- Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome
- (2020) Jared Radbel et al. CHEST
- Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019
- (2020) Yan-Ming Zeng et al. CHINESE MEDICAL JOURNAL
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
- (2020) S. Gevers et al. CLINICAL MICROBIOLOGY AND INFECTION
- COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
- (2020) Shivraj Hariram Nile et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
- (2020) Ruggero Capra et al. European Journal of Internal Medicine
- A potential protective role of losartan against coronavirus-induced lung damage
- (2020) Mehrdad Zeinalian et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Tocilizumab in COVID-19: Beware the risk of intestinal perforation
- (2020) Jens Vikse et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
- (2020) Lisheng Wang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease‐19 (COVID‐19)
- (2020) Sanket Shah et al. International Journal of Rheumatic Diseases
- COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
- (2020) Dan Zhou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures
- (2020) Durgesh Kumar et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19
- (2020) Jahan S. Khalili et al. JOURNAL OF MEDICAL VIROLOGY
- Use of subcutaneous tocilizumab in patients with COVID‐19 pneumonia
- (2020) Maria Mazzitelli et al. JOURNAL OF MEDICAL VIROLOGY
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
- (2020) Elissa Driggin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- COVID-19 with spontaneous pneumomediastinum
- (2020) Changyu Zhou et al. LANCET INFECTIOUS DISEASES
- Baricitinib for COVID-19: a suitable treatment?
- (2020) Ennio G Favalli et al. LANCET INFECTIOUS DISEASES
- Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
- (2020) Yi Xu et al. NATURE MEDICINE
- Covid-19 — The Search for Effective Therapy
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives
- (2020) Jiumeng Sun et al. TRENDS IN MOLECULAR MEDICINE
- Drug treatment options for the 2019-new coronavirus (2019-nCoV)
- (2020) Hongzhou Lu BioScience Trends
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
- (2020) Zhenwei Wang et al. BioScience Trends
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
- (2020) Philippe Gautret et al. Travel Medicine and Infectious Disease
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab
- (2020) M. Cellina et al. Diagnostic and Interventional Imaging
- The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
- (2020) Fernanda I Arnaldez et al. Journal for ImmunoTherapy of Cancer
- Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
- (2020) Erin K McCreary et al. Open Forum Infectious Diseases
- A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials
- (2020) Vaishali M. Patil et al. LIFE SCIENCES
- Current targeted therapeutics against COVID-19: Based on first-line experience in China
- (2020) Yue Zhang et al. PHARMACOLOGICAL RESEARCH
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
- (2020) R. Derwand et al. MEDICAL HYPOTHESES
- Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study
- (2019) Sarah H. Alfaraj et al. Travel Medicine and Infectious Disease
- Erectile dysfunction: a global review of intracavernosal injectables
- (2019) Catriona Duncan et al. WORLD JOURNAL OF UROLOGY
- Repurposing host-based therapeutics to control coronavirus and influenza virus
- (2019) Cui-Cui Li et al. DRUG DISCOVERY TODAY
- Simplification of Antiretroviral Treatment from Darunavir/Ritonavir Monotherapy to Darunavir/Cobicistat Monotherapy: Effectiveness and Safety in Routine Clinical Practice
- (2019) José Ramón Santos et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Influenza virus polymerase inhibitors in clinical development
- (2019) Frederick G. Hayden et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Development of a symptom assessment in patients with myelofibrosis: qualitative study findings
- (2019) Ruben A. Mesa et al. Health and Quality of Life Outcomes
- Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
- (2019) Ariane J. Brown et al. ANTIVIRAL RESEARCH
- Systemic Injection of Thalidomide Prevent and Attenuate Neuropathic Pain and Alleviate Neuroinflammatory Response in the Spinal Dorsal Horn
- (2019) Hao Xu et al. Journal of Pain Research
- HIV screening in men and women in Senegal: coverage and associated factors; analysis of the 2017 demographic and health survey
- (2019) Ndeye Aïssatou Lakhe et al. BMC INFECTIOUS DISEASES
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
- (2018) Yaseen M. Arabi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Pharmacology in HIV Therapy
- (2018) Mohamed G. Atta et al. Clinical Journal of the American Society of Nephrology
- Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis
- (2018) Kazunori Sato et al. INTERNAL MEDICINE
- Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
- (2018) Jan Haviernik et al. Viruses-Basel
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Danoprevir: First Global Approval
- (2018) Anthony Markham et al. DRUGS
- Favipiravir inhibits in vitro Usutu virus replication and delays disease progression in an infection model in mice
- (2018) Nidya A. Segura Guerrero et al. ANTIVIRAL RESEARCH
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
- (2017) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
- (2017) Erhao Zhang et al. Journal of Hematology & Oncology
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- Doubled dosage of sofosbuvir is expected for inhibiting Zika virus infection
- (2017) Somsri Wiwanitkit et al. Asian Pacific Journal of Tropical Medicine
- Airway proteases: an emerging drug target for influenza and other respiratory virus infections
- (2017) Manon Laporte et al. Current Opinion in Virology
- A reappraisal of the mucoactive activity and clinical efficacy of bromhexine
- (2017) Alessandro Zanasi et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- Relationship between Interferon Beta-1A Administration and Intracranial Vascular Tone Regulation in Patients with Relapsing-Remitting Multiple Sclerosis: A Pilot Study
- (2017) Vincenzo Dattola et al. Biomed Research International
- Hepatitis C virus NS3/4a protease inhibitors
- (2016) John A McCauley et al. CURRENT OPINION IN PHARMACOLOGY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Baricitinib in Patients with Refractory Rheumatoid Arthritis
- (2016) Mark C. Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report
- (2015) Uh Jin Kim et al. ANTIVIRAL THERAPY
- Dose regimen of favipiravir for Ebola virus disease
- (2015) France Mentré et al. LANCET INFECTIOUS DISEASES
- Siltuximab (CNTO 328): a promising option for human malignancies
- (2015) Bao-An Chen et al. Drug Design Development and Therapy
- Nucleotide Prodrug GS-5734 Is a Broad-Spectrum Filovirus Inhibitor That Provides Complete Therapeutic Protection Against the Development of Ebola Virus Disease (EVD) in Infected Non-human Primates
- (2015) Travis Warren et al. Open Forum Infectious Diseases
- Arbidol as a broad-spectrum antiviral: An update
- (2014) Julie Blaising et al. ANTIVIRAL RESEARCH
- Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus (MERS-CoV): a preliminary report of two cases
- (2014) Mohammed Khalid et al. ANTIVIRAL THERAPY
- Siltuximab: First Global Approval
- (2014) Anthony Markham et al. DRUGS
- Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen
- (2014) Nikolaos Spanakis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
- (2014) Jaffar A. Al-Tawfiq et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
- (2014) Ali S Omrani et al. LANCET INFECTIOUS DISEASES
- Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
- (2014) Frits van Rhee et al. LANCET ONCOLOGY
- Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever
- (2014) Amy L. Caroline et al. PLoS Neglected Tropical Diseases
- Meningococcal Sepsis Complicating Eculizumab Treatment Despite Prior Vaccination
- (2013) G. H. Struijk et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome
- (2013) David Safronetz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Danoprevir-Ritonavir plus Peginterferon Alfa-2a–Ribavirin in Hepatitis C Virus Genotype 1 Prior Null Responders
- (2013) Edward J. Gane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
- (2013) Margaret K. Callahan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease
- (2013) Yutong Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
- (2013) Xing-Yi Ge et al. NATURE
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
- (2013) Xin Yao et al. PHARMACOLOGY & THERAPEUTICS
- Tocilizumab – A novel therapy for non-organ-specific autoimmune diseases
- (2012) Lisa Kaly et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Favipiravir (T-705) inhibits in vitro norovirus replication
- (2012) J. Rocha-Pereira et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
- (2012) Sandrine Belouzard et al. Viruses-Basel
- Isolation and Characterization of Antitumor Alkaloid from Poppy Capsules (Papaver somniferum)
- (2012) Ibrahim Bulduk et al. Journal of Chemistry
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- Pulmonary arterial hypertension: a comparison between children and adults
- (2011) R. J. Barst et al. EUROPEAN RESPIRATORY JOURNAL
- Improved Accuracy of Methemoglobin Detection by Pulse CO-Oximetry During Hypoxia
- (2010) John R. Feiner et al. ANESTHESIA AND ANALGESIA
- Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis
- (2010) P. Brahmamdam et al. JOURNAL OF LEUKOCYTE BIOLOGY
- T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
- (2009) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Eculizumab
- (2009) Eline A. Dubois et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity
- (2009) A A Mathias et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
- (2008) Y. Boriskin et al. CURRENT MEDICINAL CHEMISTRY
- Inhalation of vasoactive intestinal peptide in pulmonary hypertension
- (2008) H. H. Leuchte et al. EUROPEAN RESPIRATORY JOURNAL
- Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells
- (2008) K. Narayanan et al. JOURNAL OF VIROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started